Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

NCT03480295 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma

Interventions

DEVICE: Hyaluronic acid 0.4% and Taurine 0.5%
DEVICE: Hyaluronic acid 0.2%

Sponsor

Fondazione G.B. Bietti, IRCCS